Active, Not Recruiting
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
NCT05036434
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea